Booz Allen Hamilton
BAH
$79.53
-2.54%
Booz Allen Hamilton Holding Corporation is a leading management and technology consulting firm, primarily serving U.S. federal government agencies with solutions in artificial intelligence, cybersecurity, and digital transformation for defense missions. The company is a dominant player in the government services and consulting sector, distinguished by its deep, long-term relationships with key defense and intelligence agencies. The current investor narrative revolves around navigating a challenging revenue environment marked by recent contract timing and budget pressures, while the market assesses the company's ability to leverage its strategic positioning in high-growth areas like AI and cyber to reignite its growth trajectory amidst fluctuating federal spending patterns.…
BAH
Booz Allen Hamilton
$79.53
Related headlines
Investment Opinion: Should I buy BAH Today?
Recommendation: Hold. The core thesis is that BAH is a financially sound company in a cyclical downturn, trading at a reasonable valuation, but lacking a near-term catalyst for a re-rating given persistent revenue headwinds and negative analyst sentiment.
Supporting evidence includes a forward P/E of 13.20x, which is low historically, and robust free cash flow generation supporting shareholder returns. However, these positives are counterbalanced by a 10.19% YoY revenue decline, net margin compression to 7.6%, and a high debt-to-equity ratio of 4.21 that amplifies risk. The stock's 26.32% annual decline and position just 10% above its 52-week low reflect these fundamental challenges.
The thesis would upgrade to a Buy if quarterly revenue growth turns positive or stabilizes, signaling an end to the downturn, or if the forward P/E compresses further toward 11x without a deterioration in cash flow. It would downgrade to a Sell if revenue decline accelerates beyond 15% YoY or if net margin falls below 5%. Relative to its own history, the stock appears fairly valued to slightly undervalued, but it is not cheap enough to discount the significant operational risks it currently faces.
Sign up to view all
BAH 12-Month Price Forecast
The outlook for BAH is one of stabilization at depressed levels rather than imminent recovery. The valuation is compelling for a patient investor, but the fundamental trend remains negative. The stock is likely to remain range-bound near current levels until revenue growth inflects. The stance would upgrade to Bullish on evidence of sequential revenue stabilization for two consecutive quarters. It would downgrade to Bearish if revenue decline accelerates or leverage concerns intensify, potentially breaking the $73.93 support level.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Booz Allen Hamilton's 12-month outlook, with a consensus price target around $103.39 and implied upside of +30.0% versus the current price.
Average Target
$103.39
10 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
10
covering this stock
Price Range
$64 - $103
Analyst target range
The stock is covered by 10 analysts, and recent institutional ratings show a predominantly neutral to bearish sentiment, with actions including 'Hold', 'Neutral', 'Underweight', and 'Sell' from firms like Stifel, Citigroup, Jefferies, Goldman Sachs, UBS, and JP Morgan. The consensus recommendation leans bearish/neutral, reflecting concerns over the recent financial performance and outlook. While the average target price is not explicitly provided in the data, the implied upside or downside cannot be calculated; the recent price action and downgrades (such as TD Cowen moving from Buy to Hold in October 2025) suggest analyst sentiment has deteriorated. The wide dispersion in recent analyst actions—from maintains of Sell/Hold ratings to a downgrade—signals high uncertainty and lack of conviction in the near-term story, with the low target likely factoring in continued revenue pressure and margin compression, while any high target would require confidence in a swift operational turnaround and reacceleration in government spending on its core service offerings.
Bulls vs Bears: BAH Investment Factors
The bearish evidence currently outweighs the bullish case, primarily due to the severe and accelerating revenue decline coupled with significant margin compression. The bull case rests on valuation support, strong cash generation, and a defensive business model, but these are reactive strengths rather than proactive growth drivers. The single most important tension in the investment debate is whether the company's deep government relationships and positioning in strategic areas like AI can reignite growth before the high financial leverage and negative momentum create a more severe downward spiral. The resolution of this growth trajectory will determine if the current valuation represents a value trap or a compelling entry point.
Bullish
- Strong Free Cash Flow Generation: The company generated $933.4 million in free cash flow over the trailing twelve months and $248 million in the latest quarter, providing ample liquidity. This robust cash flow supports shareholder returns, evidenced by $67 million in dividends and $378 million in stock repurchases in Q3, even during operational headwinds.
- Attractive Valuation Multiples: BAH trades at a trailing P/E of 14.29x and a forward P/E of 13.20x, which is near the lower end of its multi-year historical range (12x to 37x). This suggests the market has priced in significant pessimism, offering a potential value opportunity if fundamentals stabilize.
- Defensive Business Model: With a beta of 0.355, the stock exhibits low correlation to the broader market, reflecting the stability of its core U.S. federal government client base. This defensive characteristic provides downside protection, as evidenced by its relative strength outperforming the SPY by 1.93% over the last three months.
- Solid Balance Sheet Liquidity: The company maintains a strong current ratio of 1.79, indicating sufficient short-term assets to cover liabilities. This financial flexibility is crucial for navigating the current revenue contraction and funding strategic investments in high-growth areas like AI and cybersecurity.
Bearish
- Severe Revenue Contraction: Q3 revenue of $2.62 billion declined 10.19% year-over-year, continuing a concerning multi-quarter downtrend from $2.89B in Q2 and $2.92B in Q1. This sharp deceleration signals significant top-line pressure from contract timing and federal budget headwinds.
- Significant Margin Compression: Profitability has weakened substantially, with the net margin compressing to 7.6% in Q3 from 12.4% a year ago. Gross margin also fell to 51.95% from 56.7% over the same period, indicating the company is struggling to maintain profitability amid the revenue decline.
- High Financial Leverage: The company's debt-to-equity ratio of 4.21 is exceptionally high, elevating financial risk. This leverage magnifies the impact of the current earnings decline on shareholder equity and limits strategic flexibility during a downturn.
- Negative Analyst Sentiment & Downtrend: Analyst consensus is bearish/neutral with recent downgrades (e.g., TD Cowen from Buy to Hold), reflecting low conviction. The stock price is down 26.32% over the past year and 20.08% over six months, trading just 10% above its 52-week low of $73.93, confirming a strong negative trend.
BAH Technical Analysis
The stock is in a pronounced downtrend, having declined 26.32% over the past year and 20.08% over the last six months. With a current price of $83.13, it is trading near the lower end of its 52-week range of $73.93 to $130.91, positioning it approximately 10% above the 52-week low, which suggests the stock is in a zone that may attract value-oriented investors but remains under significant selling pressure. Recent momentum shows a slight divergence, with the stock up 4.96% over the past month and down 2.07% over the past three months, indicating a potential stabilization or short-term bounce within the broader downtrend, though this nascent recovery lacks conviction given the steep longer-term losses. Key technical support is clearly defined at the 52-week low of $73.93, while resistance looms far above near the 52-week high of $130.91; a sustained break below support would signal a continuation of the bearish trend, whereas reclaiming levels above $90 would be necessary to suggest a more meaningful reversal. The stock's beta of 0.355 indicates it has been significantly less volatile than the broader market (SPY) during this period, which is atypical for a name under such pressure and may reflect its defensive government client base, but this low beta also implies limited upside participation should a sector rally occur.
Beta
0.35
0.35x market volatility
Max Drawdown
-42.7%
Largest decline past year
52-Week Range
$74-$131
Price range past year
Annual Return
-26.4%
Cumulative gain past year
| Period | BAH Return | S&P 500 |
|---|---|---|
| 1m | +2.6% | +0.4% |
| 3m | -17.3% | -2.0% |
| 6m | -18.1% | +4.1% |
| 1y | -26.4% | +23.9% |
| ytd | -6.3% | -0.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BAH Fundamental Analysis
Revenue growth has decelerated sharply and turned negative, with the most recent quarterly revenue of $2.62 billion representing a 10.19% year-over-year decline, and the sequential trend from Q2 ($2.89B) and Q1 ($2.92B) shows a concerning multi-quarter contraction. The revenue segment data indicates the business is primarily driven by Cost Reimbursable Contracts ($1.515B), with Fixed-price ($521M) and Time-and-materials ($584M) contracts contributing smaller portions, but the overall trend points to broad-based top-line pressure. The company remains profitable with net income of $200 million in the latest quarter, but profitability metrics have weakened, as evidenced by a net margin of 7.6% and a gross margin of 51.95%, which have compressed from the 12.4% net margin and 56.7% gross margin reported in the year-ago quarter (Q2 2024), indicating margin pressure amid the revenue decline. The balance sheet shows a high degree of financial leverage with a debt-to-equity ratio of 4.21, which elevates risk, though this is partially offset by a solid current ratio of 1.79 indicating adequate short-term liquidity. The company generated substantial free cash flow over the trailing twelve months ($933.4 million) and $248 million in the latest quarter, providing internal funding for dividends and share repurchases, as evidenced by the $67 million in dividends paid and $378 million in stock repurchased in Q3, supporting shareholder returns despite the operational headwinds.
Quarterly Revenue
$2.6B
2025-12
Revenue YoY Growth
-0.10%
YoY Comparison
Gross Margin
+0.51%
Latest Quarter
Free Cash Flow
$933437000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BAH Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 14.29x, while the forward PE is slightly lower at 13.20x, indicating the market expects modest earnings growth or stabilization in the coming year. Compared to industry averages, which are not provided in the dataset, a direct sector premium/discount analysis cannot be quantified; however, a PE in the low-teens is generally considered reasonable for a stable, cash-generative business facing growth headwinds. Historically, the stock's own trailing PE has fluctuated significantly, ranging from approximately 12x to over 37x in recent years; the current reading of 14.29x sits near the lower end of this multi-year range, suggesting the market is pricing in a more pessimistic outlook relative to its own history, which could represent a value opportunity if fundamentals stabilize.
PE
14.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -45x~111x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are elevated. The high debt-to-equity ratio of 4.21 creates significant financial leverage, meaning any further earnings decline will disproportionately impact equity. Concurrently, revenue has contracted 10.19% YoY with net margins compressing nearly 500 basis points year-over-year, indicating operational stress. While strong free cash flow ($933M TTM) provides a buffer, the company's model remains exposed to federal budget cycles and contract award timing, creating earnings volatility.
Market & Competitive Risks center on valuation compression and growth stagnation. Trading at a forward P/E of 13.2x near its historical low suggests the market has already priced in a poor outlook, but further multiple contraction is possible if growth fails to reaccelerate. The stock's low beta of 0.355, while defensive, also implies limited participation in any broader market rally. Competitive and regulatory risks are inherent in government contracting, where budget reallocations or procurement delays can immediately impact results, as seen in the recent quarterly declines.
Worst-Case Scenario involves a continuation of the current revenue and margin downtrend, leading to credit rating concerns due to high leverage, triggering a vicious cycle of higher borrowing costs and forced asset sales. In this scenario, the stock could re-test and break below its 52-week low of $73.93. Given the stock's 42.74% maximum drawdown and current price of $83.13, a realistic adverse scenario could see a decline of approximately 11% to the 52-week low, with potential for further downside to the $65-$70 range if sentiment deteriorates severely, representing a total loss of 16-22% from current levels.
FAQ
The key risks are, in order of severity: 1) Financial Risk: High debt-to-equity (4.21) magnifies losses if earnings decline further. 2) Operational Risk: Persistent revenue contraction (-10.19% YoY) and margin compression (net margin down ~500 bps). 3) Market/Sentiment Risk: The stock is in a pronounced downtrend (-26% over 1 year) with bearish analyst consensus, risking further momentum selling. 4) Macro/Government Risk: Dependence on federal budget cycles, where delays or re-prioritizations can directly impact results.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock trading between $85-$95 as revenue stabilizes but doesn't grow. The Bull Case (25% probability) targets $105-$115 on a return to growth and margin recovery. The Bear Case (20% probability) warns of a drop to $70-$78 if the downturn worsens. The Base Case is most likely, predicated on the assumption that the current revenue decline moderates but a sharp recovery is not imminent, leaving the stock range-bound.
BAH appears fairly valued to slightly undervalued relative to its own history. Its trailing P/E of 14.29x is near the low end of its multi-year range (12x-37x), suggesting the market has priced in significant pessimism. Compared to a typical stable, cash-generative business, a low-teens P/E is reasonable, but not a deep discount given the 10% revenue decline. The valuation implies the market expects continued earnings pressure and has assigned little premium for future growth, making it undervalued only if operations stabilize or improve.
BAH is a speculative buy only for value-oriented, patient investors. At a forward P/E of 13.2x and near its 52-week low, the valuation is attractive for a company with its cash flow profile. However, with revenue declining over 10% YoY and negative analyst sentiment, it lacks a near-term growth catalyst. It could be a good buy for investors who believe federal spending on AI and cyber will rebound sooner than expected and are willing to accept the risk of further downside, potentially to the $70-$75 range, before a recovery.
BAH is unsuitable for short-term trading due to its low beta (0.355) and lack of positive momentum catalysts. It is better suited for a long-term investment horizon of 2-3 years, allowing time for its government contracting cycle to turn and for its strategic investments in AI and cyber to bear fruit. The 2% dividend yield and share repurchase program provide some return while waiting. Investors should be prepared for potential volatility and have a minimum holding period of 18-24 months to realize the value proposition.